Luminex will develop a companion diagnostic to select patients for enrollment in clinical trials with Merck's MK-8931 to treat Alzheimer's disease

Luminex Corp.

U.S. / Tools, Services, and Manufacturing

$688.0m on 03/15/2013 [market cap]

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Merck & Co. Inc.

U.S. / Large-Cap Biopharma (>=$50 billion)

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced